Vaxneuvance Європейський Союз - румунська - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - infecții pneumococice - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. vezi secțiunile 4. 4 și 5. 1 pentru informații privind protecția împotriva serotipurilor pneumococice specifice. the use of vaxneuvance should be in accordance with official recommendations.

BCG 10 ANTI-TUBERCULOSIS VACCINE Румунія - румунська - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

bcg 10 anti-tuberculosis vaccine

biomed-lublin - polonia - vaccin bcg - pulb.+solv. pt. susp. inj. - 0,05mg/doza - vaccinuri bacteriene vaccinuri tuberculoase

COVID-19 Vaccine Janssen suspensie injectabila Румунія - румунська - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

covid-19 vaccine janssen suspensie injectabila

janssen biologics b.v. - olanda - vacc. covid-19 (ad26.cov2-s[recombinant]) - susp. inj. - vaccinuri virale alte vaccinuri virale